UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Suspended
Unique ID issued by UMIN UMIN000022713
Receipt No. R000026168
Scientific Title Analyses of the clinicopathological significance of cancer-stromal interaction factors expressed in the esophageal cancer tissues
Date of disclosure of the study information 2016/07/15
Last modified on 2017/06/14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Analyses of the clinicopathological significance of cancer-stromal interaction factors expressed in the esophageal cancer tissues
Acronym Analyses of the clinicopathological significance of cancer-stromal interaction factors expressed in the esophageal cancer tissues
Scientific Title Analyses of the clinicopathological significance of cancer-stromal interaction factors expressed in the esophageal cancer tissues
Scientific Title:Acronym Analyses of the clinicopathological significance of cancer-stromal interaction factors expressed in the esophageal cancer tissues
Region
Japan

Condition
Condition Esophageal cancer
Classification by specialty
Gastroenterology Gastrointestinal surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Clarify the relationships between the image analysis of tissue microarray specimens and the clinico-pathological factors of esophageal cancer cases
Basic objectives2 Others
Basic objectives -Others Clarify the relationships between the software-assisted immunohistochemical image analysis of tissue microarray specimens and the clinico-pathological factors of esophageal cancer cases involving in the tumor growth and progression
Trial characteristics_1 Exploratory
Trial characteristics_2 Others
Developmental phase Not applicable

Assessment
Primary outcomes Post-operative recurrence-free survival and overall survival
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Approximately 300 surgically resected esophageal cancer patients at the National Cancer Center Hospital East during the period from 2000 January 1 to 2011 December 31, whom paraffin-embedded blocks of tissue microarray specimens were stored in the National Cancer Center Exploratory Oncology Research and Clinical Trial Center
Key exclusion criteria Whom specimens can not be used for analysis during the sample preparation of the tissue microarray specimens
Target sample size 300

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Hiroshi Yokozaki
Organization Kobe University Graduate School of Medicine
Division name Division of Pathology, Department of Pathology
Zip code
Address 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo Prefecture
TEL 078-382-5460
Email hyoko@med.kobe-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Mari Nishio
Organization Kobe University Graduate School of Medicine
Division name Division of Pathology, Department of Pathology
Zip code
Address 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo Prefecture
TEL 078-382-5465
Homepage URL
Email marin@med.kobe-u.ac.jp

Sponsor
Institute Kobe University Graduate School of Medicine
Institute
Department

Funding Source
Organization Japan Society for the Promotion of Science (expected)
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor National Cancer Center Exploratory Oncology Research and Clinical Trial Center Division of Pathology
National Cancer Center Hospital East Department of Gastrointestinal Oncology
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 神戸大学大学院医学研究科(兵庫県) Kobe University Graduate School of Medicine (Hyogo)
国立がん研究センター(千葉県) National Cancer Center (Chiba)

Other administrative information
Date of disclosure of the study information
2016 Year 07 Month 15 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Suspended
Date of protocol fixation
2016 Year 07 Month 11 Day
Date of IRB
Anticipated trial start date
2016 Year 10 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Suspended

Management information
Registered date
2016 Year 06 Month 13 Day
Last modified on
2017 Year 06 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026168

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.